State of the market: a review of ambulatory blood pressure monitoring devices. O'Brien E, Atkins N, Staessen J. Hypertension 1995;26:835-42.

Abstract

The introduction of 24-h ambulatory blood pressure measurement into clinical practice created a large market for ambulatory blood pressure measurement devices. Forty-three such devices from 31 manufacturers or suppliers are now available to satisfy a market demand that is likely to increase. The aim of this article is to identify the devices available and then to examine critically any validation studies assessing accuracy and performance. Of the 43 devices available 18 have been validated according to the protocols of the Association for the Advancement of Medical Instrumentation (AAMI) or the British Hypertension Society (BHS) in 25 reported studies. In nine of these studies the protocol was not adhered to, and the results, which are therefore questionable, are noted but not considered further. Fourteen devices were evaluated according to the accuracy criteria of both protocols, and of these nine fulfilled the requirements. From this review of 43 devices on the market it can be concluded that, at the time of writing, there is published evidence for only nine devices meeting the generally accepted AAMI and BHS criteria for accuracy and performance; these are the A&D TM-2420 models 6 and 7 and TM-2421, CH-Druck, Nissei ABPM DS-240, Profilomat, QuietTrak, and SpaceLabs SL-90202 and SL-90207.

Back to References

[Home] [Recommendations] [Tutorial] [References] [About]

© BHS 1999